| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/16/2005 | CN1580262A Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 02/16/2005 | CN1580261A CC10 protein preparation and use |
| 02/16/2005 | CN1580260A SiRNA and expression carrier for inhibiting human telomerase reversed transcriptive enzyme gene expression and their pharmaceutical use |
| 02/16/2005 | CN1580259A SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use |
| 02/16/2005 | CN1580258A SiRNA and expression plasmid for inhibiting human bc1-2 gene expression and their use for preparing medicine |
| 02/16/2005 | CN1580247A Esophagus carcinoma monoclonal antibody, and its radioactive marker and chemical cross-linked substance, and its use |
| 02/16/2005 | CN1580074A Bean-potato antitumour protein |
| 02/16/2005 | CN1580071A Looking-glass plant triterpene active placement, and its preparing method and use |
| 02/16/2005 | CN1580064A Tangeritin extracting technique |
| 02/16/2005 | CN1580062A Method for extracting total aglycone of Macrotys and its antitumour action |
| 02/16/2005 | CN1580056A Heterocyclic derivatives their preparing methods and uses |
| 02/16/2005 | CN1580054A Pentatomic sulphur heterocyclic compound and its use for preparing medicine for treating preventing diseases related to adiposity |
| 02/16/2005 | CN1579549A Composition medicine for curing acute early-young granulocytic leukemia |
| 02/16/2005 | CN1579537A Thymic peptide infusion and preparation process |
| 02/16/2005 | CN1579532A Method for extracting medicinal component of Yongchongcao |
| 02/16/2005 | CN1579488A Medicinal oleum curcumae Aromaticae oils and preparation for its capsule thereof |
| 02/16/2005 | CN1579463A Compound cape-jasmine salted-fermented beans total extract and its preparation and use |
| 02/16/2005 | CN1579447A Cancer prevention and treatment medicine, its preparation and using method |
| 02/16/2005 | CN1579432A Compound traditional Chinese medicine for treating fibroid and muller-iosis and its preparation method |
| 02/16/2005 | CN1579419A Medicine composition with synergistic function for treating chronic granulocytic leukemia |
| 02/16/2005 | CN1579404A Novel preparation of glycyrrhizin |
| 02/16/2005 | CN1579378A Use of alkannin in preparing medicine for treating tumor disease |
| 02/16/2005 | CN1189564C Modulators of the function of receptors of the TNF/NGF receptor family |
| 02/16/2005 | CN1189562C Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 02/16/2005 | CN1189560C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 02/16/2005 | CN1189557C Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use |
| 02/16/2005 | CN1189483C Humanized CD3-resisting monoclonal antibody |
| 02/16/2005 | CN1189482C Novel angiogenesis inhibitor |
| 02/16/2005 | CN1189481C Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof |
| 02/16/2005 | CN1189479C Use of leptin in inhibition of endothelial cell proliferation |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189465C Vitamin D3 analogs with bis C-20 side chains |
| 02/16/2005 | CN1189216C Pharmaceutical compositions containing plasma protein |
| 02/16/2005 | CN1189215C Composition and formulation for solubilizing multiple compounds and preparation method thereof |
| 02/16/2005 | CN1189214C Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 02/16/2005 | CN1189212C Mixed preparation for enhancing physical cancer cell chemical theray sensitirity |
| 02/16/2005 | CN1189203C Chinese medicaine for treating hepatocirrhosis, hepatitis and liver cancer |
| 02/16/2005 | CN1189181C Arsenic trioxide (ATO) oral slow-releasing granules and its preparation method |
| 02/16/2005 | CN1189174C Pharmaceutical compositions contg. cinchonine dichlorhydrate |
| 02/16/2005 | CN1189169C Dibenzo [a, KI] xanthene derivative used as anti-liver-cancer medicine |
| 02/15/2005 | US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 02/15/2005 | US6855812 P-glycoproteins and uses thereof |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
| 02/15/2005 | US6855723 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855712 Combination of benzoquinazoline antifolates and protecting agents |
| 02/15/2005 | US6855710 Antiproliferative agents; antitumor agents |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855702 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| 02/15/2005 | US6855698 Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 02/15/2005 | US6855696 Antitumor agents |
| 02/15/2005 | US6855693 Peptide for use in the treatment of cell damage caused by ischemia |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855688 ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use |
| 02/15/2005 | US6855686 Also administering to the subject an effective amount of an mda-7 protein. |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855528 Administering a covalently reactive antigen analog (CRAA) having an an epitope recognized irreversibly bound by catalytic antibody; autoimmune disease; a lymphoproliferative disorder; anticarcinogenic, -tumor, -inflammatory agents |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855350 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 02/15/2005 | US6855339 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 02/15/2005 | US6855308 Anticancer, antitumor agents |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/15/2005 | CA2312409C New derivatives of 7-oxo-2,3,7,14-tetrehydro-1h-benzo[b]pyrano[3,2-h]acridine carboxylate, the procedure for preparing same and the pharmaceutical compounds containing same |
| 02/15/2005 | CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids |
| 02/14/2005 | CA2477359A1 Pyruvate enriched onion extract |
| 02/10/2005 | WO2005012543A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 02/10/2005 | WO2005012536A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 02/10/2005 | WO2005012528A1 A method of preparing epitopes chimeric gene vaccine |
| 02/10/2005 | WO2005012363A1 Targeting inflammation inducer |
| 02/10/2005 | WO2005012361A2 Antibodies raised against colon carcinomas |
| 02/10/2005 | WO2005012358A2 Use of adcc-optimized antibodies for treating weak patients |
| 02/10/2005 | WO2005012357A1 Bcl-2 splicing variants |
| 02/10/2005 | WO2005012327A2 Nucleotide phosphoramidates as anticancer agents |
| 02/10/2005 | WO2005012305A2 Tricyclic parp inhibitors |
| 02/10/2005 | WO2005012269A1 Novel azole compound |
| 02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
| 02/10/2005 | WO2005012262A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 02/10/2005 | WO2005012259A1 Method of inhibiting production of osteopontin |
| 02/10/2005 | WO2005012258A1 Protein kinase inhibitor |
| 02/10/2005 | WO2005012257A1 Indazole derivatives |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005012234A1 Compounds for modulating cell proliferation |
| 02/10/2005 | WO2005012229A1 Novel bicyclic alkyl derivatives method for production of and pharmaceutical compositions comprising the same |
| 02/10/2005 | WO2005011734A2 Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer |
| 02/10/2005 | WO2005011730A1 Microsome vaccine |
| 02/10/2005 | WO2005011729A1 Human prostate cell lines in cancer treatment |
| 02/10/2005 | WO2005011725A2 Anti-angiogenetic agent and its use, in particular in cancer treatment |
| 02/10/2005 | WO2005011723A1 Preventive and/or remedy for hematopoietic tumor |
| 02/10/2005 | WO2005011715A1 Viral vectors |
| 02/10/2005 | WO2005011706A1 2-METHYLENE-19-NOR-20(S)-25-METHYL-1α-HYDROXYCALCIFEROL AND ITS USES |
| 02/10/2005 | WO2005011698A1 Combination comprising a liposome-encapsulated vinca alkaloid and a topoisomerase ii inhibitor and the use thereof for treating neoplasia |
| 02/10/2005 | WO2005011693A1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 02/10/2005 | WO2005011688A1 Cci-779 lyophilized formulations |
| 02/10/2005 | WO2005011673A1 Use of antitumoral compounds |
| 02/10/2005 | WO2005011670A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |